- Home
- OIS vs ZURA Comparison
OIS vs ZURA Comparison
Compare OIS & ZURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OIS | ZURA |
|---|---|---|
| Founded | 1995 | 2022 |
| Country | United States | United States |
| Employees | N/A | 40 |
| Industry | Metal Fabrications | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 552.6M | 455.4M |
| IPO Year | 2000 | N/A |
Fundamental Metrics
Financial Performance| Metric | OIS | ZURA |
|---|---|---|
| Price | $7.90 | $3.71 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 6 |
| Target Price | ★ $14.00 | $13.00 |
| AVG Volume (30 Days) | 661.4K | ★ 843.0K |
| Earning Date | 05-05-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.02 | N/A |
| Revenue | ★ $1,088,133,000.00 | N/A |
| Revenue This Year | $3.12 | N/A |
| Revenue Next Year | $5.89 | N/A |
| P/E Ratio | $394.00 | ★ N/A |
| Revenue Growth | ★ 62.26 | N/A |
| 52 Week Low | $4.75 | $1.00 |
| 52 Week High | $14.50 | $7.25 |
Technical Indicators
Market Signals| Indicator | OIS | ZURA |
|---|---|---|
| Relative Strength Index (RSI) | 33.03 | 41.69 |
| Support Level | $7.93 | $3.31 |
| Resistance Level | $8.71 | $4.12 |
| Average True Range (ATR) | 0.30 | 0.26 |
| MACD | 0.03 | 0.04 |
| Stochastic Oscillator | 24.75 | 47.62 |
Price Performance
Historical ComparisonAbout OIS Oil States International Inc.
Oil States International Inc is a provider of manufactured products and services to customers in the energy, military and industrial sectors. The company operates through three business segments - Offshore Manufactured Products, Completion and Production Services and Downhole Technologies. Its customers include many national oil and natural gas companies, and independent oil and natural gas companies, offshore drilling companies and other oilfield service, defense and industrial companies.
About ZURA Zura Bio Limited
Zura Bio Ltd is a clinical-stage biotechnology company developing novel medicines for patients with autoimmune and inflammatory diseases, including serious and debilitating conditions with unmet medical need. These diseases are often chronic, biologically complex, and difficult to treat, and many patients do not achieve durable disease control with existing therapies. The company has in-licensed three clinical-stage product candidates: Tibulizumab (ZB-106), a bispecific antibody targeting IL-17A and BAFF; Crebankitug (ZB-168), an IgG1 monoclonal antibody targeting IL-7R; and Torudokimab (ZB-880), an IgG4 monoclonal antibody targeting IL-33.